Cargando…

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes ~98% of tested viruses. An analysis of sera from 78...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jinghe, Ofek, Gilad, Laub, Leo, Louder, Mark K., Doria-Rose, Nicole A., Longo, Nancy S., Imamichi, Hiromi, Bailer, Robert T., Chakrabarti, Bimal, Sharma, Shailendra K., Alam, S. Munir, Wang, Tao, Yang, Yongping, Zhang, Baoshan, Migueles, Stephen A., Wyatt, Richard, Haynes, Barton F., Kwong, Peter D., Mascola, John R., Connors, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854285/
https://www.ncbi.nlm.nih.gov/pubmed/23151583
http://dx.doi.org/10.1038/nature11544
_version_ 1782430205182214144
author Huang, Jinghe
Ofek, Gilad
Laub, Leo
Louder, Mark K.
Doria-Rose, Nicole A.
Longo, Nancy S.
Imamichi, Hiromi
Bailer, Robert T.
Chakrabarti, Bimal
Sharma, Shailendra K.
Alam, S. Munir
Wang, Tao
Yang, Yongping
Zhang, Baoshan
Migueles, Stephen A.
Wyatt, Richard
Haynes, Barton F.
Kwong, Peter D.
Mascola, John R.
Connors, Mark
author_facet Huang, Jinghe
Ofek, Gilad
Laub, Leo
Louder, Mark K.
Doria-Rose, Nicole A.
Longo, Nancy S.
Imamichi, Hiromi
Bailer, Robert T.
Chakrabarti, Bimal
Sharma, Shailendra K.
Alam, S. Munir
Wang, Tao
Yang, Yongping
Zhang, Baoshan
Migueles, Stephen A.
Wyatt, Richard
Haynes, Barton F.
Kwong, Peter D.
Mascola, John R.
Connors, Mark
author_sort Huang, Jinghe
collection PubMed
description Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes ~98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site-of-vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical Arg/Lys just prior to the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 Env.
format Online
Article
Text
id pubmed-4854285
institution National Center for Biotechnology Information
language English
publishDate 2012
record_format MEDLINE/PubMed
spelling pubmed-48542852016-05-03 Broad and potent neutralization of HIV-1 by a gp41-specific human antibody Huang, Jinghe Ofek, Gilad Laub, Leo Louder, Mark K. Doria-Rose, Nicole A. Longo, Nancy S. Imamichi, Hiromi Bailer, Robert T. Chakrabarti, Bimal Sharma, Shailendra K. Alam, S. Munir Wang, Tao Yang, Yongping Zhang, Baoshan Migueles, Stephen A. Wyatt, Richard Haynes, Barton F. Kwong, Peter D. Mascola, John R. Connors, Mark Nature Article Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes ~98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site-of-vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical Arg/Lys just prior to the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 Env. 2012-09-18 2012-11-15 /pmc/articles/PMC4854285/ /pubmed/23151583 http://dx.doi.org/10.1038/nature11544 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Huang, Jinghe
Ofek, Gilad
Laub, Leo
Louder, Mark K.
Doria-Rose, Nicole A.
Longo, Nancy S.
Imamichi, Hiromi
Bailer, Robert T.
Chakrabarti, Bimal
Sharma, Shailendra K.
Alam, S. Munir
Wang, Tao
Yang, Yongping
Zhang, Baoshan
Migueles, Stephen A.
Wyatt, Richard
Haynes, Barton F.
Kwong, Peter D.
Mascola, John R.
Connors, Mark
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
title Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
title_full Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
title_fullStr Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
title_full_unstemmed Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
title_short Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
title_sort broad and potent neutralization of hiv-1 by a gp41-specific human antibody
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854285/
https://www.ncbi.nlm.nih.gov/pubmed/23151583
http://dx.doi.org/10.1038/nature11544
work_keys_str_mv AT huangjinghe broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT ofekgilad broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT laubleo broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT loudermarkk broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT doriarosenicolea broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT longonancys broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT imamichihiromi broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT bailerrobertt broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT chakrabartibimal broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT sharmashailendrak broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT alamsmunir broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT wangtao broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT yangyongping broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT zhangbaoshan broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT miguelesstephena broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT wyattrichard broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT haynesbartonf broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT kwongpeterd broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT mascolajohnr broadandpotentneutralizationofhiv1byagp41specifichumanantibody
AT connorsmark broadandpotentneutralizationofhiv1byagp41specifichumanantibody